|
Terbinafine Nitrosamines
|
|
3
|
158
|
November 14, 2024
|
|
Question about Known degradation impurity in Estazolam possibility to nitrosate (Help needed from Organic Chemists)
|
|
10
|
291
|
November 14, 2024
|
|
Requirement after reformulation of existing approved drug product for Europe
|
|
12
|
352
|
November 12, 2024
|
|
Varenicline back available in the UK
|
|
0
|
124
|
November 12, 2024
|
|
Tox Data/Testing
|
|
1
|
141
|
November 8, 2024
|
|
Analytical procedure development and proposed established conditions: A case study of a mass spectrometry based NDSRI analytical procedure -Pub
|
|
19
|
1619
|
November 6, 2024
|
|
Cinacalcet Recall
|
|
3
|
715
|
November 4, 2024
|
|
Resolution of Historically Discordant Ames Test Negative / Rodent Carcinogenicity Positive N-nitrosamines using a Sensitive, OECD-aligned Design-Pub
|
|
0
|
217
|
November 2, 2024
|
|
Share about Nitrosamines Exchange during your presentations!
|
|
7
|
651
|
September 18, 2024
|
|
NDSRI limit for N-nitroso Ciprofloxacin
|
|
2
|
225
|
November 1, 2024
|
|
⁉️ Duloxetine Impurity NDSRI
|
|
7
|
634
|
November 1, 2024
|
|
Hypothetical Nitrosamine in 1-H Indazole / CPCA Approach
|
|
3
|
119
|
October 31, 2024
|
|
N-Nitroso clonidine CPCA score
|
|
2
|
161
|
October 31, 2024
|
|
Nitrosamine Mitigation Case Study
|
|
6
|
365
|
October 31, 2024
|
|
📽 Introduction to Using (Q)SAR for the Assessment of Potential Mutagenicity of Drug Impurities
|
|
0
|
190
|
October 30, 2024
|
|
📅 Analytical challenges and the effective management of nitrosamines: The evolving landscape of NDSRI analysis
|
|
3
|
487
|
October 30, 2024
|
|
N-Nitroso mirabegron
|
|
6
|
2380
|
October 30, 2024
|
|
What is CPCA Score for “N-nitroso of 3-Amino-1,2,4-triazole"
|
|
5
|
220
|
October 30, 2024
|
|
N-Nitroso Desmethyl Tramadol
|
|
3
|
290
|
October 29, 2024
|
|
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA) -Pub
|
|
0
|
147
|
October 29, 2024
|
|
FDA Statement on Ritonavir and NITMA
|
|
1
|
210
|
October 29, 2024
|
|
Hexamethyldisilazane (HMDS) can form Nitrosamine Impurity?
|
|
7
|
498
|
October 29, 2024
|
|
N-Nitrosamine drug substance related impurities (NDSRIs) – A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da -Pub
|
|
0
|
204
|
October 28, 2024
|
|
Nitroso Betahistine Impurity C
|
|
2
|
114
|
October 28, 2024
|
|
HBTU Coupling Biproducts - Nitrosamines Risk?
|
|
3
|
177
|
October 28, 2024
|
|
Use of L-cysteine as nitrite scavenging
|
|
6
|
222
|
October 25, 2024
|
|
4000 Members Milestone 🎉
|
|
21
|
919
|
October 24, 2024
|
|
Laboratory Study in Gastric Nitrosamine Formation
|
|
1
|
135
|
October 24, 2024
|
|
Software for prediction of NDSRI generation
|
|
5
|
512
|
October 24, 2024
|
|
N-Nitroso duloxetine methods from SwissMedic and Taiwan FDA
|
|
0
|
108
|
October 24, 2024
|